Market Closed -
Bombay S.E.
06:00:58 2024-07-12 am EDT
|
5-day change
|
1st Jan Change
|
20.06
INR
|
-1.96%
|
|
-9.48%
|
+122.89%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,306
|
972.5
|
263
|
459.2
|
571.3
|
562.6
|
Enterprise Value (EV)
1 |
3,210
|
972.6
|
-36.25
|
129.2
|
425.5
|
797.1
|
P/E ratio
|
10.8
x
|
-308
x
|
-10.1
x
|
92.1
x
|
21.4
x
|
117
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.86
x
|
0.63
x
|
0.2
x
|
0.37
x
|
0.37
x
|
0.47
x
|
EV / Revenue
|
1.81
x
|
0.63
x
|
-0.03
x
|
0.1
x
|
0.28
x
|
0.66
x
|
EV / EBITDA
|
7.92
x
|
29.7
x
|
11.5
x
|
4.08
x
|
8.69
x
|
23.3
x
|
EV / FCF
|
22.4
x
|
-15.8
x
|
-0.12
x
|
3.62
x
|
-2.23
x
|
-4.22
x
|
FCF Yield
|
4.46%
|
-6.33%
|
-839%
|
27.6%
|
-44.9%
|
-23.7%
|
Price to Book
|
2.78
x
|
0.82
x
|
0.23
x
|
0.39
x
|
0.48
x
|
0.47
x
|
Nbr of stocks (in thousands)
|
96,673
|
96,673
|
96,673
|
96,673
|
96,673
|
96,673
|
Reference price
2 |
34.20
|
10.06
|
2.720
|
4.750
|
5.910
|
5.820
|
Announcement Date
|
9/5/18
|
9/14/19
|
9/7/20
|
9/6/21
|
9/7/22
|
9/4/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,778
|
1,547
|
1,298
|
1,243
|
1,531
|
1,200
|
EBITDA
1 |
405.4
|
32.76
|
-3.153
|
31.62
|
48.98
|
34.17
|
EBIT
1 |
387.7
|
12.94
|
-22.98
|
9.262
|
20.98
|
5.45
|
Operating Margin
|
21.8%
|
0.84%
|
-1.77%
|
0.75%
|
1.37%
|
0.45%
|
Earnings before Tax (EBT)
1 |
384.1
|
3.294
|
-26.99
|
7.061
|
29.6
|
9.797
|
Net income
1 |
305.5
|
-3.163
|
-26.14
|
4.987
|
26.73
|
4.68
|
Net margin
|
17.18%
|
-0.2%
|
-2.01%
|
0.4%
|
1.75%
|
0.39%
|
EPS
2 |
3.160
|
-0.0327
|
-0.2703
|
0.0516
|
0.2765
|
0.0498
|
Free Cash Flow
1 |
143.2
|
-61.61
|
304.1
|
35.65
|
-190.9
|
-188.8
|
FCF margin
|
8.05%
|
-3.98%
|
23.43%
|
2.87%
|
-12.47%
|
-15.74%
|
FCF Conversion (EBITDA)
|
35.32%
|
-
|
-
|
112.73%
|
-
|
-
|
FCF Conversion (Net income)
|
46.87%
|
-
|
-
|
714.89%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/5/18
|
9/14/19
|
9/7/20
|
9/6/21
|
9/7/22
|
9/4/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
0.09
|
-
|
-
|
-
|
234
|
Net Cash position
1 |
96.3
|
-
|
299
|
330
|
146
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.002669
x
|
-
|
-
|
-
|
6.86
x
|
Free Cash Flow
1 |
143
|
-61.6
|
304
|
35.6
|
-191
|
-189
|
ROE (net income / shareholders' equity)
|
29.5%
|
-0.27%
|
-2.23%
|
0.43%
|
2.27%
|
0.39%
|
ROA (Net income/ Total Assets)
|
17.2%
|
0.54%
|
-0.96%
|
0.38%
|
0.85%
|
0.2%
|
Assets
1 |
1,772
|
-589.1
|
2,724
|
1,311
|
3,156
|
2,379
|
Book Value Per Share
2 |
12.30
|
12.30
|
12.00
|
12.00
|
12.30
|
12.40
|
Cash Flow per Share
2 |
0.4800
|
-0.0900
|
0.8700
|
1.320
|
0.0700
|
0.3800
|
Capex
1 |
145
|
55.5
|
9.06
|
21.4
|
90.1
|
361
|
Capex / Sales
|
8.14%
|
3.59%
|
0.7%
|
1.72%
|
5.89%
|
30.06%
|
Announcement Date
|
9/5/18
|
9/14/19
|
9/7/20
|
9/6/21
|
9/7/22
|
9/4/23
|
|
1st Jan change
|
Capi.
|
---|
| +122.89% | 23.22M | | +3.74% | 104B | | -10.18% | 59.99B | | +80.95% | 50.92B | | +8.46% | 36.09B | | -0.02% | 30.95B | | +4.78% | 18.85B | | +18.14% | 17.61B | | +9.26% | 13.97B | | +78.32% | 13B |
Other Commodity Chemicals
|